Association between tissue TMB (tTMB) and clinical outcomes with pembrolizumab monotherapy (pembro) in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and-042 trials-MedSci.cn

Association between tissue TMB (tTMB) and clinical outcomes with pembrolizumab monotherapy (pembro) in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and-042 trials

Herbst, RS; Lopes, G; Kowalski, DM; Nishio, M; Wu, YL; de Castro, G; Baas, P; Kim, DW; Gubens, MA; Cristescu, R; Aurora-Garg, D; Albright, A; Ayers, M; Loboda, A; Lunceford, J; Kobie, J; Lubiniecki, GM; Pietanza, MC; Piperdi, B; Mok, TSK

ANNALS OF ONCOLOGY, 2019; 30 (): 916

科室
- - 订阅+
  - 更多科室
工具
服务